PeptideDB

MERS-CoV-IN-1

CAS: 2245697-92-9 F: C19H17NO2 W: 291.34

MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical co
Data collection：peptidedb@qq.com
Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS) (extracted from patent WO2018174442A1, compound 1)[1].
Target MERS-CoV and SARS
Name MERS-CoV-IN-1
CAS 2245697-92-9
Formula C19H17NO2
Molar Mass 291.34
Appearance Solid
Transport Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Reference [1]. Compound for treating diseases caused by coronavirus infection. Patent WO2018174442A1.

iKIX1

SARS-CoV-2-IN-6

Product Recommendation

Latest release

Hot list

Copyright © 2025 PeptideDB All Rights Reserved

Sitemaps | Contact

Is for research use only, not for human use. We do not sell to patients.